Pharmaceutical

Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility

DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing…

2 months ago

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical…

2 months ago

IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives

MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OCTQB: IGXT; TSX: IGX), a leading drug…

2 months ago

Jaguar Health, Inc. Announces Reverse Stock Split

Reverse split approved at April 2024 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted…

2 months ago

Akanda Corp. Announces Subsequent Registered Direct Offering

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

2 months ago

Akanda Announces Closing of Registered Direct Offering

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

2 months ago

Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

New Initiatives Showing Encouraging ResultsSHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir"…

2 months ago

Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand

CHICAGO, IL / ACCESSWIRE / May 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

2 months ago

Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage…

2 months ago